Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong

March 24, 2026 updated by: Dr. Christy Lai-ming Hui, The University of Hong Kong

A Cluster Randomized Controlled Trial of Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong

This cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of a narrative therapy (NT) intervention in (i) reducing mental distress, depressive symptoms, and anxiety, as well as (ii) enhancing perceived control and fostering a stronger sense of self among at-risk youth in Hong Kong. Participants are youths with moderate mental health concerns, indicated by K6 scores ranging from 11 to 14.

The study involves seven clusters, each based on community hubs, which will be randomly assigned to either the intervention group or a wait-list control group. Clusters assigned to the intervention group will receive six face-to-face sessions led by trained youth workers. Control clusters will receive the same intervention after the initial follow-up period.

Participants will be evaluated at baseline, post-intervention, and one-month follow-up. An interim analysis is built for the sake of evaluation of the collected data from the ongoing trial, in which the primary research question is addressed, and which has the potential for modifying the conduct of the study. Furthermore, a qualitative follow-up will be conducted after the trial, involving both participants and the workers delivering the NT intervention. This qualitative component aims to gather feedback on participants' experiences, and inform potential revisions to enhance future implementation.

It is hypothesized that youths receiving the NT intervention will show significantly greater improvements in perceived control and sense of self, along with reductions in mental distress, as well as depressive and anxiety symptoms, compared to those in the wait-list control group.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

770

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Christy Lai Ming Hui, PhD
  • Phone Number: +852 2255 4486
  • Email: christy@lmhui.com

Study Contact Backup

  • Name: Yi Nam Suen, PhD
  • Phone Number: +852 3917 6612
  • Email: suenyn@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • University of Hong Kong
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • JC LevelMind @ Community users at risk for mental distress (Tier 2), with K6 scores ranging from 11 to 14
  • Aged between 12 and 24 years
  • Sufficiently proficient in Chinese to comprehend verbal instructions
  • Able to provide written informed consent (parental consent for participant aged 12-17)

Exclusion Criteria:

  • Known diagnosis of intellectual disability
  • Organic brain disorder
  • Established psychiatric diagnosis
  • Current substance abuse
  • Receiving other structured psychological therapies such as module-based psychological therapy, mentalization-based therapy, low-intensity online interventions, cognitive-behavioral therapy, cognitive-behavioral therapy for insomnia, mindfulness, or art-informed therapy within the hub setting or any others outside the hub setting
  • Presence of current or active suicidal ideation or attempts

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: NT Intervention
This narrative therapy intervention will: (i) facilitate shared experiences among participants, (ii) support the reconstruction of personal identity, (iii) promote collective wisdom-sharing and skill development; and (iv) foster solidarity in imagining diverse life possibilities. This approach empowers young people to critically engage with dominant narratives and discover their own authentic paths. The NT intervention consists of six sessions, conducted in a small-group format (6 - 8 participants per group). Youths at similar life stages, such as secondary students, university students, and early-career young professionals, will be grouped together to encourage meaningful discussions and shared experiences. The program consists of six sessions, with the first five lasting 1.5 hours each, and the final session (Section 6) extending to 2 hours for a comprehensive closing. All sessions will be conducted face-to-face by frontline social or youth workers who have received prior training,
In Hong Kong, deeply ingrained norms and expectations shape each stage of life. As young people navigate their growth, they are constantly influenced by mainstream narratives stemming from sociocultural traditions, family, educators, peers, or social media. These narratives often define socially approved notions of "good" versus "bad," "meaningful" versus "meaningless," and "successful" versus "failing." Many youths may not fully realize how these dominant discourses subtly influence their life choices, often leading them to unconsciously accept predetermined paths they believe they "should" follow. Whether they conform successfully or struggle with these expectations, young people frequently experience pressure and negative emotions. Even more concerning, some internalize these societal judgments, resulting in negative self-perceptions. Through this group program utilizing narrative intervention methods, we aim to provide a safe, supportive space for youth to re-examine and explore th
No Intervention: Waitlist Control
Participants allocated to the waitlist control group will wait for 10 weeks (6 + 4 weeks) before receiving the NT intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Distress
Time Frame: Baseline, 6-week, and 10-week
The 6-item Kessler Psychological Distress Scale (scores range from 0 to 24 where a higher score indicates a worse outcome)
Baseline, 6-week, and 10-week
Depression and anxiety Symptoms
Time Frame: Baseline, 6-week, and 10-week
Depression Anxiety Stress Scales (scores range from 0 to 63 where a higher score indicates more severe symptoms)
Baseline, 6-week, and 10-week
Perceived Control / Self-efficacy
Time Frame: Baseline, 6-week, and 10-week
Sense of Mastery Scale (scores range from 7 to 28 where a higher score indicates a a better outcome)
Baseline, 6-week, and 10-week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Narrative Identity
Time Frame: Baseline, 6-week, and 10-week
Narrative Identity Self-Evaluation Scale (scores range from 0 to 200 where a higher score indicates a better outcome)
Baseline, 6-week, and 10-week
Perceived Social Support
Time Frame: Baseline, 6-week, and 10-week
Multidimensional Scale of Perceived Social Support (scores range from 12 to 84 where a higher score indicates a better outcome)
Baseline, 6-week, and 10-week
Loneliness
Time Frame: Baseline, 6-week, and 10-week
UCLA Loneliness Scale (scores range from 20 to 80 where a higher score indicates a worse outcome)
Baseline, 6-week, and 10-week
Resilience
Time Frame: Baseline, 6-week, and 10-week
The 10-item Connor-Davidson Resilience Scale (scores range from 0 to 40 where a higher score indicates a better outcome)
Baseline, 6-week, and 10-week
Rumination
Time Frame: Baseline, 6-week, and 10-week
The 22-item Rumination-Reflection Questionnaire (scores range from 22 to 88 where a higher score greater rumination)
Baseline, 6-week, and 10-week
Self-stigma
Time Frame: Baseline, 6-week, and 10-week
The 9-item Internalized Stigma of Mental Illness Inventory (scores range from 1 to 4 where a higher score indicating high internalized stigma)
Baseline, 6-week, and 10-week
Hopefulness / Hopelessness
Time Frame: Baseline, 6-week, and 10-week
Beck Hopelessness Scale (scores range from 0 to 20 where a higher score indicates greater levels of hopelessness)
Baseline, 6-week, and 10-week
Service Utilization
Time Frame: Baseline, 6-week, and 10-week
Client Service Receipt Inventory
Baseline, 6-week, and 10-week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2025

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

August 27, 2025

First Submitted That Met QC Criteria

November 13, 2025

First Posted (Actual)

November 17, 2025

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Distress

Clinical Trials on Narrative Therapy

Subscribe